Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SAB Biotherapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 275K | Mar 14, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SABS | SAB Biotherapeutics, Inc. | Mar 14, 2023 | 1 | $0 | 4 | Mar 16, 2023 | Chief Financial Officer |
SABS | SAB Biotherapeutics, Inc. | Sep 13, 2022 | 1 | $0 | 4 | Sep 15, 2022 | CHIEF FINANCIAL OFFICER |
SABS | SAB Biotherapeutics, Inc. | Mar 16, 2022 | 1 | $0 | 4 | Mar 18, 2022 | Chief Financial Officer |
SABS | SAB Biotherapeutics, Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Chief Financial Officer |
SABS | Big Cypress Acquisition Corp. | Oct 22, 2021 | 0 | $0 | 3 | Oct 22, 2021 | Chief Financial Officer |
SABS | SAB Biotherapeutics, Inc. | Oct 18, 2021 | 6 | $25.5K | 4 | Nov 16, 2021 | Chief Financial Officer |